Vancouver ↔ Seoul | Cross-Border Commercialization

Bridging North American MedTech Innovation with South Korea

Helping North American MedTech companies successfully enter the Korean healthcare market through strategic market access, Key Opinion Leader (KOL) engagement, and accelerated commercialization specialized in gastroenterology and GI health.

Schedule a Consultation Explore Market Data

Cross-Border Infrastructure

Seamless Market Access Corridor

Linking innovative medical device technology with top-tier university hospitals and GI Key Opinion Leaders across South Korea.

North American Origin Vancouver HQ

South Korea Operations Seoul Commercial Operations

Regulatory Strategy Product-Specific MFDS Pathway

Clinical Focus Area Gastroenterology (GI) Healthcare

Market Opportunity

Unlocking South Korea's High-Growth GI Market

South Korea represents one of the most dynamic, high-volume healthcare markets for gastroenterology innovation in Asia.

Approximately 100,000+

Diagnosed IBD Patients

Over the past decade, Inflammatory Bowel Disease (Crohn’s Disease & Ulcerative Colitis) prevalence in South Korea has surged rapidly, surpassing 100,000+ registered patients due to Westernized lifestyle shifts.

Millions

Annual Colonoscopies

Backed by South Korea’s National Cancer Screening Program, millions of screening and therapeutic endoscopies are conducted annually, driving sustained demand for advanced diagnostic and therapeutic devices.

Rapid

Clinical Technology Adoption

Top-tier university hospital GI centers in South Korea offer world-class clinical efficiency and eager technology adoption by leading global Key Opinion Leaders (KOLs).

Regional Expansion Strategy

South Korea as a Strategic Gateway to Asia

South Korea offers a highly developed healthcare ecosystem and concentrated access to leading clinical institutions and specialists. VanKor focuses on establishing strong commercial and clinical foundations in South Korea, creating a credible reference market that can support broader expansion across Asia as opportunities arise.

North American Innovation

→

South Korea Market Entry

→

Clinical & Commercial Reference

→

Broader Asia Expansion

Our Process

The VanKor Commercialization Framework

A structured pathway from North American innovation to Korean clinical adoption.

Market Assessment

Evaluate clinical need, competitive landscape, regulatory considerations, and market potential in South Korea.

Regulatory & Market Access

Define the appropriate MFDS pathway and coordinate regulatory, reimbursement, and market-access requirements with qualified local partners.

KOL & Clinical Adoption

Engage relevant clinical experts and institutions to support evaluation, clinical adoption, and development of credible reference sites.

Market Entry & Commercial Launch

Develop the initial market-entry strategy, establish hospital access, and execute the commercial launch with the appropriate local channel structure.

Commercial Scale-Up

Expand hospital and channel coverage based on early market evidence, clinical adoption, and commercial performance.

Target Portfolio Criteria

Focus GI Solution Categories

VanKor focuses on bringing differentiated North American medical technologies to South Korea across four core gastroenterology domains:

Endoscopic Accessories & Procedure Enhancement

Procedure-enhancing technologies designed to improve scope navigation, procedural efficiency, visualization, and physician ergonomics across diagnostic and therapeutic endoscopy.

Key Fit: Procedural Efficiency & Physician-Centered Innovation

Continence & Bowel Dysfunction

Non-surgical, discreet internal continence inserts and post-operative recovery solutions designed for accidental bowel leakage (ABL), neurogenic bowel care, and colorectal surgical rehabilitation.

Key Fit: Minimally Invasive Patient-Centered Care

GI Motility & Monitoring

Wearable, wireless sensor patch systems providing real-time electrogastrography (EGG) and gut bio-electric activity monitoring for gastroparesis, chronic constipation, and post-operative ileus (POI).

Key Fit: Real-Time Diagnostic Clinical Evidence

Capsule & Endoscopic Diagnostics

Next-generation 360° panoramic capsule endoscopy and specialized endoscopic technologies enhancing diagnostic precision for IBD (Crohn’s & Ulcerative Colitis) and small bowel pathologies.

Key Fit: High-Volume Screening Infrastructure

Leadership & Clinical Advisory

Proven Multinational Commercial Track Record

Helmed by commercial leaders with extensive leadership experience at premier global healthcare and life sciences multinationals, ensuring top-tier execution for North American products in South Korea.

Vancouver, Canada

Minwoo Lee

Founding Partner

10+ Years Experience

Leveraging commercial leadership roles at premier global healthcare corporations including Johnson & Johnson (IBD Commercial) and Merck (Primary Care), Minwoo possesses the top-tier strategic capability required to successfully introduce and position North American medical technologies in the South Korean market.

Grounded in 10+ years of healthcare strategy and quantitative discipline from UNC Chapel Hill (Mathematics & Statistics), Minwoo orchestrates strategic alignment between foreign device manufacturers and premier Korean gastroenterology centers.

Core Expertise

Global Pharma & MedTech Leadership KOL Engagement Cross-Border Expansion

Seoul, South Korea

Korea-Based Operating Partner

Market Access & Operations

20+ Years Experience

A seasoned healthcare executive with over 20+ years of comprehensive commercial experience spanning top global pharmaceutical, medical device, and life science leaders including Johnson & Johnson, Pfizer, and Thermo Fisher Scientific.

Possesses an extensive track record across Sales & Marketing, Market Access, Regulatory Affairs, and Reimbursement Strategy, ensuring seamless market entry and rapid clinical adoption in top-tier South Korean hospital systems.

Core Expertise

Global Multinationals (J&J, Pfizer, ThermoFisher) Market Access & HIRA Sales & Marketing Leadership

🩺

Clinical Advisory Network

Guided by practicing clinicians and gastroenterologists in Canada and South Korea to assess technology fit and clinical adoption considerations.

Canadian Practicing Physicians South Korean GI Clinicians

Core Capabilities

End-to-End Market Access Solutions

Regulatory & Market Access

Coordinating product-specific MFDS regulatory pathways, market-access requirements, and applicable accelerated or alternative entry mechanisms with qualified Korean regulatory partners.

KOL Engagement & Clinical Adoption

Connecting innovative MedTech products directly with premier gastroenterology professors and clinical testing centers to accelerate adoption.

Commercialization & Channel Strategy

We design and execute market-entry and channel strategies tailored to each technology, from initial hospital access and commercial launch through scalable channel development.

Ready to Expand Your MedTech Reach into South Korea?

Partner with VanKor MedTech Solutions to accelerate South Korea market entry and establish a foundation for broader expansion across Asia.

Contact Information

Company VanKor MedTech Solutions

Founding Partner Minwoo Lee (Vancouver)

Korea Operations Seoul, South Korea

Email minwoo@vankormed.com

Website www.vankormed.com

Locations Greater Vancouver, BC | Seoul, South Korea

Send Direct Email

Connect on LinkedIn

Scan QR code to connect directly with Minwoo Lee on LinkedIn

Open LinkedIn Profile →